Navin Fluorine International Q4 FY25 earnings call: Revenue & Margins
Q4 FY25 earnings call: what management said on revenue, margins and capex.
- Revenue
- ₹701Cr
- +16.4% YoY
- +15.7% QoQ
- Net profit
- ₹95Cr
- +35.7% YoY
- +13.1% QoQ
- Margin
- 26%
- +8 pp YoY
- +2 pp QoQ
Guidance rank: #18 of 70 in Chemicals & Petrochemicals
See the sector's top 10 — free with your mobile number.
Navin Fluorine International Ltd Q4 FY25 key numbers
- Revenue
- Fluoro specialty project (INR 540 crores capex) is ramping up with 50-55% utilization expected by end FY '26, contributing to revenue growth.
As stated in Navin Fluorine International Ltd's Q4 FY25 earnings call transcript · published 3 Aug 2026. Reported figures, not investment advice.
The short version
Navin Fluorine aims to grow its CDMO business to $100 million revenue by FY '27, supported equally by existing contracts, new MSAs, and base business. Navin Fluorine targets to maintain an Operating EBITDA margin around 25% (between 23%-27%) for FY '26, striving for stability amid market uncertainties.
From Navin Fluorine International Ltd's Q4 FY25 earnings-call transcript · updated 23 Aug 2026.
Revenue & Sales Performance
- Navin Fluorine aims to grow its CDMO business to $100 million revenue by FY '27, supported equally by existing contracts, new MSAs, and base business.
- The company sees strong growth in the liquid cooling market, expected to grow from $0.5 billion today to $3 billion by 2035, including two-phase immersion cooling liquids.
- Fluoro specialty project (INR 540 crores capex) is ramping up with 50-55% utilization expected by end FY '26, contributing to revenue growth.
- New capacity for R32 refrigerant is servicing global markets, with healthy pricing and strategic partnerships in discussion.
2 more points from Navin Fluorine International Ltd's call on revenue
Create a free account to keep reading this call
Profitability & Margins
See what Navin Fluorine International Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Fluoro Specialty Project: Commercial production started Dec 2024 at Dahej facility; ramping up well.
- Surat Expansion: INR 30 crores expansion initiated dispatches from Feb 2025.
- CGMP4 Capex: INR 288 crores planned; Phase 1 (INR 160 crores) on track for commissioning by Q3 FY '26.
- Opteon Project with Chemours: $14 million capex; initial capacity set up to accelerate market adoption, with potential for further capacity expansion.
- CDMO Business: Strategic investment with capex run rate approx. INR 500-600 crores for FY '26.
- Margins targeted at around 25% with ongoing efforts.
2 more points from Navin Fluorine International Ltd's call on capex
Create a free account to keep reading this call
Top-ranked in Chemicals & Petrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Navin Fluorine International Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
- Navin Fluorine is working on 10 to 15 commercial or late-stage products in the CDMO vertical with growth potential.
- A commercial order from a U.S. major is expected for delivery in FY '26, following a successful scale-up order delivered in Q4 FY '25.
- Multiple inquiries for R32 capacity came much before the capacity became operational, indicating strong demand.
- Discussions with global majors for strategic partnerships on new capacities are ongoing.
- The initial production capacity for Opteon is sufficient to support several field trials to accelerate market adoption.
2 more points from Navin Fluorine International Ltd's call on order book
Create a free account to keep reading this call
Navin Fluorine International Ltd — Quarterly revenue & net profit
Navin Fluorine International Ltd Q4 FY25 results — key figures
| ₹ Cr | Q4 FY25 | Q4 FY24 | YoY | Q3 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue | 701 | 602 | +16.4% | 606 | +15.7% |
| Operating profit (EBITDA) | 179 | 110 | +62.7% | 147 | +21.8% |
| Operating margin | 26% | 18% | +8 pp | 24% | +2 pp |
| Profit before tax | 127 | 79 | +60.8% | 108 | +17.6% |
| Net profit (PAT) | 95 | 70 | +35.7% | 84 | +13.1% |
| EPS (₹) | 19.15 | 14.19 | +35% | 16.86 | +13.6% |
Source: reported quarterly figures (Screener), ₹ crore.
Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹1.2K Cr, net profit ₹269 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Navin Fluorine International's management said in earlier quarters
Others in Chemicals & Petrochemicals this season
- Atul (Q4 FY25)
Consolidated revenue from operations for 2024-25: ₹5,583 cr, 18% increase YoY from ₹4,726 cr in 2023-24 (Page 36). Key concall takeaways from Atul Ltd's Q4…
- Vidhi Specialty (Q4 FY25)
109.5 Crs, up 40.2% YoY (from Rs. Key concall takeaways from Vidhi Specialty Food Ingredients Ltd's Q4 FY25 earnings call — and how it ranks against sector…
- Chemcon Speciality Chemicals (Q4 FY25)
54.9 Crs, down 8% YoY from Rs. Key concall takeaways from Chemcon Speciality Chemicals Ltd's Q4 FY25 earnings call — and how it ranks against sector peers.
- Valiant Organics (Q4 FY25)
Q4-FY25 revenue from operations (consolidated) was INR 2,038 million, a 15.3% year-on-year (YoY) increase from INR 1,768 million in Q4-FY24 (Page 12 and 10)…
Potential multibaggers · Q2 FY27
Potential multibaggers in Chemicals & Petrochemicals
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Navin Fluorine International Ltd and 15K+ more earnings calls,
for less than your morning chai
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Navin Fluorine International Ltd Q4 FY25 results?
Navin Fluorine aims to grow its CDMO business to $100 million revenue by FY '27, supported equally by existing contracts, new MSAs, and base business. Navin Fluorine targets to maintain an Operating EBITDA margin around 25% (between 23%-27%) for FY '26, striving for stability amid market uncertainties.
What is Navin Fluorine International Ltd share price analysis?
Navin Fluorine International Ltd currently shows a neutral. The stock trades at a P/E of 53.1 with a market cap of ₹42,251 Cr. Investors should review the full earnings analysis for detailed insights.
Is Navin Fluorine International Ltd planning capital expenditure?
Fluoro Specialty Project: Commercial production started Dec 2024 at Dahej facility; ramping up well. - Surat Expansion: INR 30 crores expansion initiated dispatches from Feb 2025. - CGMP4 Capex: INR 288 crores planned; Phase 1 (INR 160 crores) on track for commissioning by Q3 FY '26. - Opteon Project with Chemours: $14 million capex; initial capacity set up to accelerate market adoption, with potential for further capacity expansion. - CDMO Business: Strategic investment with capex run rate approx.
Keep Navin Fluorine International Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.
